- Infliximab, Is It Really a New Horizon for the Treatment of Kawasaki Disease?
-
Eun LY
- KMID: 2432138
- Korean Circ J.
- 2019 Feb;49(2):192-193.
- doi: 10.4070/kcj.2018.0460
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Treatment of Tolosa-Hunt Syndrome after a Single Infusion of Infliximab
-
Halabi T, Sawaya R
- KMID: 2399616
- J Clin Neurol.
- 2018 Jan;14(1):126-127.
- doi: 10.3988/jcn.2018.14.1.126
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease
-
Lee JL
- KMID: 2464334
- Ann Coloproctol.
- 2019 Oct;35(5):225-226.
- doi: 10.3393/ac.2019.10.11
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
-
Im JP
- KMID: 2425154
- Intest Res.
- 2017 Apr;15(2):147-148.
- doi: 10.5217/ir.2017.15.2.147
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Type II Segmental Vitiligo Developed under Infliximab Treatment for Ulcerative Colitis
-
Ryu TH, Lee DW, Choi JE, Ahn HH, Kye YC, Seo SH
- KMID: 2395206
- Ann Dermatol.
- 2017 Dec;29(6):826-827.
- doi: 10.5021/ad.2017.29.6.826
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Infliximab-induced Psoriasis in Treatment of Ankylosing Spondylitis
-
Kim MJ, Lee JH, Im HJ, Yeo HJ, Lee HJ, Byun KS
- KMID: 2222954
- J Rheum Dis.
- 2014 Oct;21(5):274-277.
- doi: 10.4078/jrd.2014.21.5.274
Infliximab, which is indicated for refractory rheumatoid arthritis (RA), ankylosing spondylitis (AS) and Crohn's disease, has cutaneous adverse events including skin rash, urticaria, pruritus, and lupus-like eruption. Psoriasis induced by... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of Renal Disorder in a Patient Receiving Infliximab (Remicade(R)) for Psoriasis
-
Kim DH, Lee JH, Kim TY
- KMID: 2246331
- Korean J Dermatol.
- 2014 Jul;52(7):494-497.
Infliximab (Remicade(R)) has been used for treating many chronic inflammatory diseases, including rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, and psoriasis. Complications such as infusion reaction and infection in infliximab therapy... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy of Infliximab in Refractory Uveitis
-
Kim JH, Lee DW, Cho NC
- KMID: 2213838
- J Korean Ophthalmol Soc.
- 2016 Jan;57(1):50-55.
- doi: 10.3341/jkos.2016.57.1.50
PURPOSE: To investigate the effectiveness of infliximab as treatment for refractory uveitis that recurred in spite of immunosuppressive agents. METHODS: Thirty patients who were treated for refractory uveitis from 2002 to... -
- CITED
-
- Close
- SHARE
-
- Close
- Infliximab: Effective Therapy for Pustular Psoriasis
-
Petro A, Crofford L, Kang S
- KMID: 2171843
- Ann Dermatol.
- 2003 Dec;15(4):149-150.
- doi: 10.5021/ad.2003.15.4.149
Pustular psoriasis is often resistant to the standard therapies used to treat psoriasis vulgaris. Methotrexate, acitretin, and cyclosporine have been reported to be beneficial in the treatment of both psoriasis... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Trends of Infliximab Treatment for Crohn's Disease
-
Kim MJ, Choe YH
- KMID: 2315315
- Pediatr Gastroenterol Hepatol Nutr.
- 2012 Mar;15(1):19-22.
Crohn's disease is a chronic inflammatory disorder of the gastrointestinal tract and characterized by relapsing and remitting episodes, with progression over time to complications of stricture, fistulas, or abscesses. The... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Multiple Tuberculosis Associated with Infliximab Therapy in Crohn's Disease
-
Kim HW, Jang SI, Kim B, Youn YH, Byun MK, Park HJ, Lee SI
- KMID: 2263454
- Korean J Med.
- 2012 Sep;83(3):337-341.
Infliximab, a tumor necrosis factor-alpha (TNF-alpha) inhibitor, has been approved for the treatment of a variety of inflammatory illnesses, including Crohn's disease. However, infliximab can increase the risk of reactivation... -
- CITED
-
- Close
- SHARE
-
- Close
- Infliximab for Treatment of Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome: A Case Report
-
Hirohata A, Hanafusa T, Kawamoto T, Ikegami R
- KMID: 2368051
- Ann Dermatol.
- 2017 Feb;29(1):131-133.
- doi: 10.5021/ad.2017.29.1.131
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Gram-negative Septicemia after Infliximab Treatment in an Infant with Refractory Kawasaki Disease
-
Lee JH, Yoon JM, Lim JW, Ko KO, Cheon EJ
- KMID: 2279100
- Korean J Pediatr Infect Dis.
- 2014 Dec;21(3):225-230.
- doi: 10.14776/kjpid.2014.21.3.225
Kawasaki disease (KD) is an immune-mediated disease which is a leading cause of acquired cardiovascular disease in developed country. Recently, tumor necrosis factor-alpha (TNF-alpha) blocker, infliximab has been considered a... -
- CITED
-
- Close
- SHARE
-
- Close
- Remission of Cap Polyposis Maintained for More Than Three Years after Infliximab Treatment
-
Kim ES, Jeen YT, Keum B, Seo YS, Chun HJ, Um SH, Kim CD, Ryu HS
- KMID: 2284155
- Gut Liver.
- 2009 Dec;3(4):325-328.
Cap polyposis is a rare disorder with characteristic endoscopic and histological features; its etiology is still unknown, and no specific treatment has been established. We report a case of cap... -
- CITED
-
- Close
- SHARE
-
- Close
- Occurrence of tuberculous pleurisy associated with infliximab therapy
-
Lee YS, Jung JO, Hong JH, Seo YI, Eom KS, Jang SH, Jung KS
- KMID: 2306017
- Korean J Med.
- 2004 Oct;67(4):421-424.
Infliximab is a chimeric antibody against tumor necrosis factor-alpha and it can be used in the treatment of ankylosing spondylitis. Tumor necorosis factor-alpha is a potent proinflammatory cytokine and plays... -
- CITED
-
- Close
- SHARE
-
- Close
- Phlegmonous gastritis in an ankylosing spondylitis patient treated with infliximab
-
Kim BY, Kim HS
- KMID: 2411504
- Korean J Intern Med.
- 2017 Sep;32(5):945-946.
- doi: 10.3904/kjim.2016.158
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Pityrosporum Fungal Infection Following Infliximab Therapy in a Crohn's Disease Patient
-
Shin KY, Heo J, Jung MK, Jeon SW, Kim SK
- KMID: 2284936
- Intest Res.
- 2010 Dec;8(2):177-180.
- doi: 10.5217/ir.2010.8.2.177
Crohn's disease (CD) is a chronic immune-mediated inflammatory disorder. Treatment strategies for CD are targeted toward various components of the proinflammatory mediators and subsequent immune response. Recently, the anti-tumor necrosis... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Miliary Tuberculosis in a Patient with Behcet's Disease and Uveitis Receiving Infliximab
-
Yoo JW, Roh JH, Park JW, Kim YG, Jang JW, Na SY, Shim TS
- KMID: 2319284
- Tuberc Respir Dis.
- 2009 Nov;67(5):454-457.
Infliximab, a TNF-alpha antagonist, has been used to treat refractory rheumatoid arthritis, ankylosing spondylitis, Crohn's disease and Behcet's disease. Tuberculosis (TB) is a well-known opportunistic infection in patients receiving infliximab.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Tuberculous Peritonitis in a Patient with Ankylosing Spondylitis during Infliximab Therapy
-
Kang JY, Park SH, Kwok SK
- KMID: 2268965
- Korean J Med.
- 2015 Nov;89(5):593-597.
- doi: 10.3904/kjm.2015.89.5.593
Infliximab is a chimeric monoclonal antibody against tumor necrosis factor-alpha (TNF-alpha) that is used to treat chronic inflammatory diseases such as ankylosing spondylitis (AS). Side effects include greater susceptibility to... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Hypopigmented Mycosis Fungoides in a Patient with Ankylosing Spondylitis during Treatment with Infliximab
-
Kim SR, Jeong DS, Moon YS, Jeong HB, Kim CY
- KMID: 2350803
- Korean J Dermatol.
- 2016 Feb;54(2):160-161.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
